Class II
Ongoing
Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-286-23; N…
Why: Presence of Particulate Matter: Hair was found in products
- Company
- Fresenius Kabi USA, LLC
Lake Zurich, IL, United States - Reported
- Jul 29, 2026
- Recall started
- Jul 16, 2026
- Where sold
- Nationwide within in the USA
- Amount
- 92,600 vials
- Full product description
- Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-286-23; NDC Vial: 63323-286-05
- Lots / codes affected
- Lot #: 6133436, Exp. Date 10/2028
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.